Cargando…
Inhibition of P-glycoprotein by two artemisinin derivatives
P-Glycoprotein/MDR1 represents an important component of the blood brain barrier and contributes to multidrug resistance. We investigated two derivatives of the anti-malarial artemisinin, SM616 and GHP-AJM-3/23, concerning their ability to interact with P-glycoprotein. The ability of the two compoun...
Autores principales: | Steglich, Babette, Mahringer, Anne, Li, Ying, Posner, Gary H., Fricker, Gert, Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131583/ http://dx.doi.org/10.1007/s13659-012-0006-3 |
Ejemplares similares
-
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
por: Soomro, Shahid, et al.
Publicado: (2011) -
Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers
por: Arav-Boger, Ravit, et al.
Publicado: (2010) -
Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918
por: Wallstab, A, et al.
Publicado: (1999) -
Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function
por: Muzzammil, T, et al.
Publicado: (2001) -
Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)